Amanda Reeck, MD
Assistant Professor / Clinical
Amanda Reeck, MD is an Assistant Professor / Clinical at UT Health San Antonio in the Division of General and Hospital Medicine. She has been a Hospitalist for University Hospital since 2014. Dr. Reeck received her M.D. from Baylor College of Medicine in 2011. She completed Residency in 2014 from UT Southwestern Medical Center Dallas, TX. Dr. Reeck acquired the American Board of Internal Medicine Certification in August 2014. She is part of the Medicine Clerkship Faculty and serves as the Site Director for the Internal Medicine Residency Program at University Hospital. She was awarded the Outstanding Faculty Medicine Clerkship Award in 2017, 2018, and 2020. Dr. Reeck has also had significant involvement throughout her career in global health, serving as faculty mentor for medical student global health experiences, as well as helping to establish and mentor the IM residency program Global Health elective. She is the director of the Clinical Education Tract for the IM residency program.
- 2014 - Internal Medicine - Residency - UT Southwestern Internal Medicine Program
- 2011 - MD - Medicine - Baylor College of Medicine
- 2003 - Bachelor of Science - Biology - Pensacola Cristian College
Research & Grants
These Aren’t the Clots You’re Looking For: An Unusual Presentation of Venous Thromboembolism. Eric Lorio, Lorelle Knight, Amanda Reeck. TX ACP, Nov 2018.
On the Other Side: An Educational Innovation To Help Learners Understand Communication Barriers. Amanda Reeck, Christopher Moreland, Keri Richardson. Society of Hospital Medicine, Las Vegas Nevada, May 1-4, 2017
A Hint of MAC, A Dash of C. Diff, What Else is Cooking in the Petri Dish? The Case of an Unusual Polymicrobial Infection. Damilola Jibowu, Parth Desai, Amanda Reeck. TX ACP, San Antonio, TX, Nov 2017.
Serological Responses to Experimental Norwalk Virus Infection Measured Using a Quantitative Duplex Time-Resolved Fluorescence Immunoassay Kavanagh O, Estes MK, Reeck A, Raju RM, Opekun AR, Gilger MA, Graham DY, Atmar RL, Clin Vaccine Immunol.2011 Jul; (7): 1187-90. PMID: 21593238
Pegylated interferon on ribavirin promote early evolution of nonstructural 5A protein in individuals with hepatitis C who demonstrate a response to treatment. Jain MK, Yuan HJ, Adams-Huet B, Reeck A, Shelton J, Attar N, Zhang S. Neunmann AU, Carney DS, Gale M Jr, Lee WM. Journal of Infectious Disease. 2009 Sep 15; 200(6): 866-76.
- American Board of Internal Medicine